Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 986 | 933 | 904 | 758 | 987 | 2121 |
Fund Return | -1.39% | -6.74% | -9.64% | -8.84% | -0.26% | 7.81% |
Place in category | 308 | 399 | 287 | 171 | 162 | 19 |
% in Category | 62 | 75 | 57 | 49 | 77 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bosera S&P 500 QDII | 13.55B | 18.94 | 11.14 | 13.03 | ||
BoseraYufu CSI 300 Index Fund C | 6B | -1.65 | -9.20 | - | ||
Bosera Theme Industry Stock FdLOF | 5.58B | -6.70 | -15.37 | 7.35 | ||
Bosera MedicalHlth Care Set Secs A | 2.4B | -17.90 | -19.60 | 5.44 | ||
Bosera Value Growth Fund | 2B | 1.76 | -9.81 | 3.33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ChinaAMC CSI 300 Exchange Traded | 99.22B | -1.17 | -9.84 | 5.56 | ||
E Fund SSE50 Index | 20.67B | 2.75 | -5.91 | 10.81 | ||
Huaan Shanghai SSE180 Index | 19.19B | 1.95 | -6.92 | 5.82 | ||
E Fund CSI300 ETF Feeder Fund | 14.27B | -0.86 | -8.90 | 5.67 | ||
Fullgoal CSI 300 Strengthen Fund | 11.45B | 0.07 | -9.12 | 8.66 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kweichow Moutai | CNE0000018R8 | 5.16 | 1,640.00 | +2.81% | |
Ping An Insurance | CNE000001R84 | 2.89 | 58.50 | +5.03% | |
Amperex Tech A | CNE100003662 | 2.72 | 258.00 | +1.18% | |
Midea Group A | CNE100001QQ5 | 2.19 | 78.30 | +4.39% | |
Industrial Bank | CNE000001QZ7 | 1.92 | 19.40 | +4.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review